chr14-102319901-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018335.6(ZNF839):āc.136G>Cā(p.Glu46Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,272,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018335.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZNF839 | NM_018335.6 | c.136G>C | p.Glu46Gln | missense_variant | 1/8 | ENST00000442396.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZNF839 | ENST00000442396.7 | c.136G>C | p.Glu46Gln | missense_variant | 1/8 | 5 | NM_018335.6 | A2 | |
ZNF839 | ENST00000558850.5 | c.-61+2235G>C | intron_variant | 2 | P2 | ||||
ZNF839 | ENST00000559185.5 | c.-61+383G>C | intron_variant | 2 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000199 AC: 3AN: 150538Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000205 AC: 23AN: 1121360Hom.: 0 Cov.: 30 AF XY: 0.0000201 AC XY: 11AN XY: 546068
GnomAD4 genome AF: 0.0000199 AC: 3AN: 150650Hom.: 0 Cov.: 32 AF XY: 0.0000136 AC XY: 1AN XY: 73588
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 19, 2024 | The c.136G>C (p.E46Q) alteration is located in exon 1 (coding exon 1) of the ZNF839 gene. This alteration results from a G to C substitution at nucleotide position 136, causing the glutamic acid (E) at amino acid position 46 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at